Vimarsana
Biggest News Aggregation in the World

Page 3 - Pharma Index News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Index. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Index Today - Breaking & Trending Today

Nifty: 4 stocks Jay Thakkar is bullish on from pharma sector - Vimarsana News

Nifty: 4 stocks Jay Thakkar is bullish on from pharma sector

​The momentum had definitely weakened out there, we did see some consolidation happening out there but there was no price correction as like that of Nifty and Bank Nifty.

Looking for value: Time to buy healthcare funds? - Vimarsana News

Looking for value: Time to buy healthcare funds?

There are 18 pharma-healthcare sector funds, including seven passively managed schemes, which manage assets worth Rs 15,240 crore as on June 30, 2023. Some of these schemes invest in healthcare stocks listed overseas. Are they offering good value?

Pharmaceutical Contract Manufacturing Organization (CMO) - Vimarsana News

Pharmaceutical Contract Manufacturing Organization (CMO)

The Pharmaceutical Contract Manufacturing Organization (CMO) Market size is estimated at USD 161.37 billion in 2023, and is expected to reach USD 210.50...

Ten best bets for next 3-4 weeks as bulls go slow on scaling new highs - Vimarsana News

Ten best bets for next 3-4 weeks as bulls go slow on scaling new highs

The index is likely to consolidate in the monthly F&O expiry week, and if the index takes support and rebounds, then 18,700-18,900 could be the resistance area, whereas 18,500-18,450 could be the next crucial support in case of correction in coming sessions

Buy or sell: Sumeet Bagadia recommends these three stocks to buy on Monday - June 5 - Vimarsana News

Buy or sell: Sumeet Bagadia recommends these three stocks to buy on Monday - June 5

As investors await RBI monetary policy announcement and foreign investment. Choice Broking recommends buying Bajaj Finserv, Dr Reddy's, and SBI.